Whitebox Advisors LLC Amryt Pharma PLC Transaction History

Whitebox Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $3.17 Million - $3.74 Million	466,712 New	466,712 $3.23 Million
Q2 2022 Aug 15, 2022	SELL	$6.85 - $8.87 $3.2 Million - $4.14 Million	-466,712 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.3 - $10.86 $924,228 - $1.59 Million	146,703 Added 45.84%	466,712 $3.86 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $3.08 Million - $3.99 Million	320,009 New	320,009 $3.86 Million
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.29 $2.89 Million - $3.79 Million	-265,346 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.22 - $14.16 $76,717 - $88,896	-6,278 Reduced 2.31%	265,346 $3.76 Million
Q3 2020 Nov 13, 2020	BUY	$10.8 - $13.5 $2.93 Million - $3.67 Million	271,624 New	271,624 $3.34 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Whitebox Advisors LLC with notifications on news.